Oculis Holding AG (OCS) Current Leases (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Current Leases of $531233.9 for Q1 2026, up 57.11% year-over-year from $338124.2 in Q1 2025, and down 15.42% quarter-over-quarter from $628087.2 in Q4 2025.
Oculis Holding AG (OCS) Current Leases (2021 - 2026) Analysis & Trends
Oculis Holding AG's Current Leases history runs 6 years deep, the most recent figure standing at $531233.9 for Q1 2026.
- In Q1 2026, Current Leases rose 57.11% year-over-year to $531233.9; the TTM figure through Mar 2026 stood at $531233.9 (up 57.11% YoY), while the FY2025 annual figure was $605476.5, up 69.1% from the prior year.
- Current Leases for Q1 2026 stood at $531233.9, down from $628087.2 in the prior quarter.
- The five-year high for Current Leases was $628087.2 in Q4 2025, with the low at $147399.1 in Q4 2022.
- The 5-year median for Current Leases is $359579.4 (2024), against an average of $341289.4.
- The sharpest annual moves came in 2022 and 2024: Current Leases slipped 29.58% in 2022, then soared 83.69% in 2024.
- Oculis Holding AG's Current Leases stood at $147399.1 in 2022, then jumped by 33.08% to $196159.7 in 2023, then surged by 83.31% to $359579.4 in 2024, then jumped by 74.67% to $628087.2 in 2025, then retreated by 15.42% to $531233.9 in 2026.
- Business Quant data shows OCS's Current Leases at $531233.9 in Q1 2026, $628087.2 in Q4 2025, and $526296.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 950,194.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 950,194.57 |
| Mar 31, 2026 | 531,233.95 |
| Dec 31, 2025 | 628,087.24 |
| Sep 30, 2025 | 526,296.11 |
| Jun 30, 2025 | 374,445.97 |
| Mar 31, 2025 | 338,124.16 |
| Dec 31, 2024 | 359,579.38 |
| Sep 30, 2024 | 362,421.07 |
| Jun 30, 2024 | 361,594.47 |
| Mar 31, 2024 | 208,514.18 |
| Dec 31, 2023 | 196,159.68 |
| Sep 30, 2023 | 206,051.77 |
| Jun 30, 2023 | 196,855.07 |
| Dec 31, 2022 | 147,399.11 |
| Dec 31, 2021 | 209,308.90 |